by Nate Wooley | February 7, 2013 1:00 pm
The U.S. Food and Drug Administration is advising doctors about another batch of counterfeit drugs.
The FDA says the fake version of the cancer-fighting drug Avastin contains none of the active ingredients, reports the Associated Press. This is the third counterfeit batch of Avastin — made by Roche (PINK:RHHBY) — to be caught this year.
The batches are labeled “Altuzan,” which is the Turkish version of Avastin. Avastin is an injectable cancer-fighting drug used to treat lung, brain, kidney and colon cancers. However, Altuzan is not approved for use in the U.S. at all.
In a release on its website, the FDA says the counterfeit drugs come from one of these companies: Medical King, Pharmacological or Taranis Medical. Any medical professionals with these drugs from these companies should stop using them and contact the FDA immediately.
Source URL: http://investorplace.com/2013/02/fda-warns-docs-as-more-fake-cancer-drugs-hit-u-s/
Short URL: http://invstplc.com/1nvQYGK
Copyright ©2017 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.